Connecticut Capital Management Group, LLC

Position in LLY — ELI LILLY & Co

CIK 2097898 MILFORD, CT

Position in LLY

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,246,207

+$309,882 QoQ

Shares Held

1,039

+2.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.10%

of 13F equity value

Holder Rank

#2,930

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Connecticut Capital Management Group, LLC holds $3,815,550 across 6 Drug Manufacturers - General names. LLY ranks #1 (32.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	1,039	$1,246,207
2	JNJ	Johnson & Johnson	3,217	$817,020
3	ABBV	AbbVie Inc.	3,151	$792,916
4	MRK	Merck & Co., Inc.	3,415	$438,827
5	AMGN	Amgen Inc	744	$269,417
6	GILD	Gilead Sciences, Inc.	1,988	$251,163

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,246,207	1,039	+2.1%	Shares	Sole	2026-07-20
2026-03-31	$936,325	1,018	-1.5%	Shares	Sole	2026-04-13
2025-12-31	$1,111,219	1,034	—	Shares	Other	2026-02-09
No filing history on record for this holder in this stock.